Stoke Therapeutics, Inc. ( STOK ) Q3 2026 Earnings Call October 29, 2026 4:30 PM EDT

Company Participants

Thomas Leggett - Chief Financial Officer

Ian Smith - CEO & Director

Barry Ticho - Chief Medical Officer

Jason Hoitt - Chief Patient Officer

Conference Call Participants

Kevin Strang - Goldman Sachs Group, Inc., Research Division

Laura Chico - Wedbush Securities Inc., Research Division

Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division

John Cox - Jefferies LLC, Research Division

Sumant Kulkarni - Canaccord Genuity Corp., Research Division

Yaron Werber - TD Cowen, Research Division

Joseph Stringer - Needham & Company, LLC, Research Division

Jessica Fye - JPMorgan Chase & Co, Research Division

Marc Goodman - Leerink Partners LLC, Research Division

Guofang Li - Wolfe Research, LLC

Yatin Suneja - Guggenheim Securities, LLC, Research Division

Presentation

Operator

Good day, and thank you for standing by.…